These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34859515)

  • 1. Response to Luz & Mash on cardiac toxicity of ibogaine.
    Schellekens A; Kramers K; Knuijver T; Belgers M; Donders R; Verkes RJ
    Addiction; 2022 Mar; 117(3):837-838. PubMed ID: 34859515
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse.
    Luz M; Mash DC
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1019-1022. PubMed ID: 34139922
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.
    Knuijver T; Schellekens A; Belgers M; Donders R; van Oosteren T; Kramers K; Verkes R
    Addiction; 2022 Jan; 117(1):118-128. PubMed ID: 33620733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence.
    Knuijver T; Belgers M; Markus W; Verkes RJ; van Oosteren T; Schellekens A
    J Clin Psychopharmacol; 2018 Dec; 38(6):646-648. PubMed ID: 30300292
    [No Abstract]   [Full Text] [Related]  

  • 5. Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report.
    Cloutier-Gill L; Wood E; Millar T; Ferris C; Eugenia Socias M
    J Psychoactive Drugs; 2016; 48(3):214-7. PubMed ID: 27192438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.
    Brown TK; Alper K
    Am J Drug Alcohol Abuse; 2018; 44(1):24-36. PubMed ID: 28541119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias.
    Grogan J; Gerona R; Snow JW; Kao L
    J Emerg Med; 2019 Oct; 57(4):e99-e104. PubMed ID: 31630892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-addiction drug ibogaine and the heart: a delicate relation.
    Koenig X; Hilber K
    Molecules; 2015 Jan; 20(2):2208-28. PubMed ID: 25642835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification.
    Davis AK; Renn E; Windham-Herman AM; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(4):287-297. PubMed ID: 30020025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to Knuijver et al. on the 'Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study'.
    Luz M; Mash DC
    Addiction; 2022 Mar; 117(3):835-836. PubMed ID: 34542215
    [No Abstract]   [Full Text] [Related]  

  • 11. Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.
    Noller GE; Frampton CM; Yazar-Klosinski B
    Am J Drug Alcohol Abuse; 2018; 44(1):37-46. PubMed ID: 28402682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.
    Malcolm BJ; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(3):256-265. PubMed ID: 29608409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DARK Classics in Chemical Neuroscience: Ibogaine.
    Wasko MJ; Witt-Enderby PA; Surratt CK
    ACS Chem Neurosci; 2018 Oct; 9(10):2475-2483. PubMed ID: 30216039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ibogaine medical subculture.
    Alper KR; Lotsof HS; Kaplan CD
    J Ethnopharmacol; 2008 Jan; 115(1):9-24. PubMed ID: 18029124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of death due to ibogaine use for heroin addiction: case report.
    Jalal S; Daher E; Hilu R
    Am J Addict; 2013; 22(3):302. PubMed ID: 23617876
    [No Abstract]   [Full Text] [Related]  

  • 16. Mania following use of ibogaine: A case series.
    Marta CJ; Ryan WC; Kopelowicz A; Koek RJ
    Am J Addict; 2015 Apr; 24(3):203-205. PubMed ID: 25877487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.
    Vastag B
    Science; 2005 Apr; 308(5720):345-6. PubMed ID: 15831735
    [No Abstract]   [Full Text] [Related]  

  • 18. A non-hallucinogenic psychedelic analogue with therapeutic potential.
    Cameron LP; Tombari RJ; Lu J; Pell AJ; Hurley ZQ; Ehinger Y; Vargas MV; McCarroll MN; Taylor JC; Myers-Turnbull D; Liu T; Yaghoobi B; Laskowski LJ; Anderson EI; Zhang G; Viswanathan J; Brown BM; Tjia M; Dunlap LE; Rabow ZT; Fiehn O; Wulff H; McCorvy JD; Lein PJ; Kokel D; Ron D; Peters J; Zuo Y; Olson DE
    Nature; 2021 Jan; 589(7842):474-479. PubMed ID: 33299186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder.
    Brown TK; Noller GE; Denenberg JO
    J Psychoactive Drugs; 2019; 51(2):155-165. PubMed ID: 30967101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac arrest after ibogaine ingestion.
    Vlaanderen L; Martial LC; Franssen EJ; van der Voort PH; Oosterwerff E; Somsen GA
    Clin Toxicol (Phila); 2014 Jul; 52(6):642-3. PubMed ID: 24940646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.